Related Experiment Video
Updated: Aug 4, 2026

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations
Published on: January 10, 2015
Tobacco cessation through dental office settings
1Oregon Research Institute, Eugene 97403-1983, USA. judith@ori.orgTI Tobacco cessation through dental office settings.
Abstract:
There is increasing interest in broadly inclusive public health interventions that involve low-cost, self-help materials and minimal support from professionals. Dental health care workers (DHCWs) are a largely untapped resource for providing advice and brief counseling to tobacco-using patients, and there are good reasons to believe that they can be effective in this role. The results of our randomized clinical trials have shown that a brief dental office-based intervention can be effective in helping smokeless tobacco users to quit and smokers to reduce their use and become more ready to quit. A third clinical trial tested the effectiveness of two methods of disseminating the smokeless tobacco intervention to DHCWs throughout the western United States. Workshops were more effective than self-study in effecting behavior change, although our analyses indicate that self-study was more cost-efficient. These studies have demonstrated the viability of using dentists and dental hygienists to provide brief cessation advice and supportive materials in the context of regular oral health visits to encourage their patients to quit. The results of these studies also support the timeliness of further dissemination and diffusion of this program to practitioners, dental schools, and dental hygiene programs.
More Related Videos
06:39Electroencephalographic, Heart Rate, and Galvanic Skin Response Assessment for an Advertising Perception Study: Application to Antismoking Public Service Announcements
Published on: August 28, 2017
06:12Using Nicotine in a Silica-Exposed Mouse Model to Promote Lung Epithelial-Mesenchymal Transition
Published on: March 3, 2023
Related Concept Videos
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Tonsillitis II: Management
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Acute Coronary Syndrome IV: Interprofessional Care